Choosing the cerebral cortex of mice (1-3 days old) to extract primary astrocytes, the cortex was digested by 0.125%
trypsin-EDTA (Gibco, Grand Island, NY, USA), then centrifuged and incubated in
DMEM/F12 complete medium (Gibco, Thermo Fisher Scientific, Waltham, MA, USA). After 9-11 days, the cells were shaken at 260 rpm at 37° C for 16 h to purify. Finally, purified astrocytes were obtained.
Choosing the cortex of fetal mice (16–18 days old) to isolate primary neurons, the culture flasks were pretreated with
poly-d-lysine (PDL) (Sigma-Aldrich, St. Louis, MO, USA). The fragment was digested with 0.125% trypsin and grown with
DMEM (Gibco, Grand Island, NY, USA) for 5 h, then replaced with
neurobasal medium containing 2% B27 (Gibco, Grand Island, NY, USA) and 0.5 mmol/L
glutamine (Sigma-Aldrich, St. Louis, MO, USA).
Choosing Adult Brain Dissociation Kit and
ACSA-2 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) for magnetic isolation of astrocytes from adult mice. The former was used to digest the cortex. Then, purified astrocytes were obtained. Astrocytes were incubated for 15 min at 4° C with
ACSA-2 MicroBeads and separated from single-cell suspension in a magnetic field using MS columns,
MACS MultiStand and
QuadroMACS (Miltenyi Biotec, Bergisch Gladbach, Germany).
Hu J., Duan H., Zou J., Ding W., Wei Z., Peng Q., Li Z., Duan R., Sun J, & Zhu J. (2024). METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes. Aging (Albany NY), 16(1), 299-321.